Correlation Between Celldex Therapeutics and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Celldex Therapeutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celldex Therapeutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celldex Therapeutics and Puma Biotechnology, you can compare the effects of market volatilities on Celldex Therapeutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celldex Therapeutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celldex Therapeutics and Puma Biotechnology.
Diversification Opportunities for Celldex Therapeutics and Puma Biotechnology
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Celldex and Puma is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Celldex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celldex Therapeutics are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Celldex Therapeutics i.e., Celldex Therapeutics and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Celldex Therapeutics and Puma Biotechnology
Given the investment horizon of 90 days Celldex Therapeutics is expected to under-perform the Puma Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Celldex Therapeutics is 1.36 times less risky than Puma Biotechnology. The stock trades about -0.01 of its potential returns per unit of risk. The Puma Biotechnology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 458.00 in Puma Biotechnology on August 29, 2024 and sell it today you would lose (144.00) from holding Puma Biotechnology or give up 31.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Celldex Therapeutics vs. Puma Biotechnology
Performance |
| Timeline |
| Celldex Therapeutics |
| Puma Biotechnology |
Celldex Therapeutics and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Celldex Therapeutics and Puma Biotechnology
The main advantage of trading using opposite Celldex Therapeutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celldex Therapeutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Celldex Therapeutics vs. Ideaya Biosciences | Celldex Therapeutics vs. AnaptysBio | Celldex Therapeutics vs. MeiraGTx Holdings PLC | Celldex Therapeutics vs. Keros Therapeutics |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |